These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17065001)

  • 1. Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine.
    Mottl H; Starý J; Chánová M; Nekolná M; Drahokoupilová E; Smelhaus V
    Leuk Lymphoma; 2006 Sep; 47(9):1881-4. PubMed ID: 17065001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.
    Rodriguez-Galindo C; Kelly P; Jeng M; Presbury GG; Rieman M; Wang W
    Am J Hematol; 2002 Mar; 69(3):179-84. PubMed ID: 11891804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients.
    Stine KC; Saylors RL; Williams LL; Becton DL
    Med Pediatr Oncol; 1997 Oct; 29(4):288-92. PubMed ID: 9251735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
    Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
    Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis.
    Pardanani A; Phyliky RL; Li CY; Tefferi A
    Mayo Clin Proc; 2003 Mar; 78(3):301-6. PubMed ID: 12630583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis.
    Stine KC; Saylors RL; Saccente S; McClain KL; Becton DL
    Pediatr Blood Cancer; 2004 Jul; 43(1):81-4. PubMed ID: 15170896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and toxicity of 2-CDA in Langerhans cell histiocytosis: a single institutional experience.
    Biswas G; Khadwal A; Arora B; Bhagwat R; Banavali SD; Nair CN; Pai SK; Kurkure PA; Parikh PM
    Indian J Cancer; 2007; 44(4):137-41. PubMed ID: 18322355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment results of Langerhans cell histiocytosis with LSH II protocol].
    Mottl H; Ganevová M; Radvanská J; Chánová M; Smelhaus V; Kodet R; Mrhalová M; Tichý M
    Cas Lek Cesk; 2005; 144(11):753-5. PubMed ID: 16335702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker.
    Aerni MR; Aubry MC; Myers JL; Vassallo R
    Respir Med; 2008 Feb; 102(2):316-9. PubMed ID: 17935961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review.
    Néel A; Artifoni M; Fontenoy AM; Tessoulin B; Lorillon G; Cohen-Aubart F; Haroche J; Genereau T; de Menthon M; Guillevin L; Maillard H; Kahn JE; Hermine O; Araujo C; Dromer C; Jullien D; Hamidou M; Donadieu J; Tazi A
    Br J Haematol; 2020 Jun; 189(5):869-878. PubMed ID: 32191819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
    Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
    Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of treatment with 2-chlorodeoxyadenosine in refractory or relapsed Langerhans cell histiocytosis. Study of 9 patients].
    Grau J; Ribera JM; Tormo M; Indiano JM; Vercher J; Sandoval V; Ramírez G; Sastre A; Flores E; García-Conde J
    Med Clin (Barc); 2001 Mar; 116(9):339-42. PubMed ID: 11333766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoside analogues in the therapy of Langerhans cell histiocytosis: a survey of members of the histiocyte society and review of the literature.
    Weitzman S; Wayne AS; Arceci R; Lipton JM; Whitlock JA
    Med Pediatr Oncol; 1999 Nov; 33(5):476-81. PubMed ID: 10531572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes insipidus and Langerhans cell histiocytosis: a case report of reversibility with 2-chlorodeoxyadenosine.
    Ottaviano F; Finlay JL
    J Pediatr Hematol Oncol; 2003 Jul; 25(7):575-7. PubMed ID: 12847329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Langerhans cell histiocytosis with 2 chlorodeoxyadenosine.
    Dimopoulos MA; Theodorakis M; Kostis E; Papadimitris C; Moulopoulos LA; Anastasiou-Nana M
    Leuk Lymphoma; 1997 Mar; 25(1-2):187-9. PubMed ID: 9130627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis].
    Hu T; Liu R; Li J; Cao J; Zhang L; Li J; Fan W; Zhong D; Shi X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):985-9. PubMed ID: 25417874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
    Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
    Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH.
    Evseev D; Osipova D; Kalinina I; Raykina E; Ignatova A; Lyudovskikh E; Baidildina D; Popov A; Zhogov V; Semchenkova A; Litvin E; Kotskaya N; Cherniak E; Voronin K; Burtsev E; Bronin G; Vlasova I; Purbueva B; Fink O; Pristanskova E; Dzhukaeva I; Erega E; Novichkova G; Maschan A; Maschan M
    Blood Adv; 2023 Sep; 7(18):5246-5257. PubMed ID: 37216396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine.
    Choi SW; Bangaru BS; Wu CD; Finlay JL
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):503-6. PubMed ID: 12794533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients].
    Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J
    Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.